Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應用
6-(4-(Hydroxymethyl)piperidin-1-yl)pyridazine-3-carboxylic Acid is a bifunctional compound that can be used for targetting the degradation of androgen receptors to potentially treat cancer of Kennedy’s disease, or both.
參考文獻
Crew, A.P., et.al.: U.S. Pat. Appl. Publ., 605, (2018);
滬ICP備17019645號
400-821-0725
